Humacyte HUMA
NASDAQ HUMA
$0.57 -0.01 (-1.43%)
As of: Sep 10, 2026 · 2:49 PM EDT

Humacyte (HUMA) Inventory Average (2025 - 2026)

Humacyte's (HUMA) quarterly Inventory Average came in at $19.3 million in Q2 2026, up 102.11% year-over-year from $9.6 million in Q2 2025, and down 10.01% quarter-over-quarter from $21.5 million in Q1 2026.

Analysis

Humacyte (HUMA) Inventory Average (2025 - 2026) Analysis & Trends

Humacyte (HUMA) has reported Inventory Average for 2 consecutive years, with $19.3 million the latest figure, recorded in Q2 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Krystal Biotech 10.21 Bn 9.36 Bn 112.79 Mn 44.10 Mn
2 CRISPR Therapeutics AG 5.02 Bn 5.02 Bn - -
3 Iovance Biotherapeutics 3.64 Bn 3.34 Bn 55.72 Mn 56.98 Mn
4 Legend Biotech 3.53 Bn 2.57 Bn 251.50 Mn 39.30 Mn
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn -
6 Beam Therapeutics 2.53 Bn 2.53 Bn - -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 17.49 Mn
8 Sarepta Therapeutics 2.15 Bn 1.35 Bn 251.87 Mn 952.69 Mn
9 Vericel 1.93 Bn 1.76 Bn 56.40 Mn 18.37 Mn
10 Humacyte 133.72 Mn 133.72 Mn -825,000.00 19.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.32 Mn
Mar 31, 2026 21.47 Mn
Dec 31, 2025 20.46 Mn
Sep 30, 2025 14.76 Mn
Jun 30, 2025 9.56 Mn